The increase in pro-inflammatory cytokines, including IL-6, IFN-γ, and TNF-α, has been proven in patients with COVID-19 and found to be associated with COVID-19 disease severity, and thus, some patients have responded to IL-6 blockade (25, 26). This evidence concerns the gene IFNG and COVID-19.